ATC Group: S01G Decongestants and antiallergics

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01G in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01G Decongestants and antiallergics

Group S01G contents

Code Title
S01GA Sympathomimetics used as decongestants
S01GX Other antiallergics

Active ingredients in S01G

Active Ingredient Description
Alcaftadine

Alcaftadine is an H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.

Azelastine

Azelastine, a phthalazinone derivative is classified as a potent long-acting anti-allergic compound with selective H1 antagonist properties. An additional anti-inflammatory effect could be detected after topical ocular administration. Data from in vivo (pre-clinical) and in vitro studies show that azelastine inhibits the synthesis or release of the chemical mediators known to be involved in early and late stage allergic reactions e.g. leukotriene, histamine, PAF and serotonin.

Brimonidine

Brimonidine is an alpha2-adrenergic receptor agonist that is 1000-fold more selective for the alpha2-adrenoceptor than the alpha1-adrenoreceptor. This selectivity results in no mydriasis and the absence of vasoconstriction in microvessels associated with human retinal xenografts.

Cromoglicic acid

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.

Emadine

Emedastine is a potent selective and topically effective histamine H1 antagonist. In vivo topical ocular administration of emedastine produces a concentration-dependent inhibition of histamine-stimulated conjunctival vascular permeability.

Epinastine

Epinastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H1-receptor and has affinity for the histamine H2receptor. Epinastine also possesses affinity for the α1, α2, and 5-HT2–receptors.

Ketotifen

Ketotifen is a histamine H1-receptor antagonist. In vivo animal studies and in vitro studies suggest the additional activities of mast cell stabilisation and inhibition of infiltration, activation and degranulation of eosinophils.

Levocabastine

Levocabastine is a potent, fast-acting and highly selective histamine H1-antagonist with a sustained duration of action.

Lodoxamide

Lodoxamide is a mast cell stabiliser that inhibits the in vivo Type I immediate hypersensitivity reaction in animals and man.

Naphazoline

Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity.

Nedocromil

Nedocromil is a non-steroidal agent, which has anti-inflammatory properties when administered topically in the lung. In the treatment of bronchial asthma, nedocromil sodium reduces bronchospasm, cough and bronchial hyperreactivity and improves objective measurements of lung function.

Olopatadine

Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action.

Oxymetazoline

Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa.

Phenylephrine

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.

Tetryzoline

Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa.

Xylometazoline

Xylometazoline acts directly on α-adrenoreceptors but does not act on β-receptors. When used topically as a nasal decongestant, xylometazoline acts rapidly and provides long-lasting relief. Onset of action is within minutes, the decongestant effect being prolonged and lasting for up to 10 hours.

Related product monographs

Title Information Source Document Type  
ALBALON Eye drops, solution Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC
ALLERCROM Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ALOMIDE Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ELESTAT Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/PLR
Emadine 0.05% w/v, Eye drops, Solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EMADINE Eye drops, solution European Medicines Agency (EU) MPI, EU: SmPC
KETOFALL Eye drops, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
LASTACAFT Solution (Drops) FDA, National Drug Code (US) MPI, US: SPL/PLR
LOMIDE Eye drops, solution Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
NALCROM Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OPATANOL Eye drops, solution European Medicines Agency (EU) MPI, EU: SmPC
OPTICROM Allergy Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OPTILAST Eye drops Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PATADAY Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/PLR
PATANOL Eye drops, solution FDA, National Drug Code (US) MPI, US: SPL/Old
PAZEO Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/PLR
RELESTAT Eye drops, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
TILADE Pressurised inhalation suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
Vividrin Eye Drops 2% sodium cromoglicate Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ZADITEN Eye drops, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
ZADITEN Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC